These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1916938)

  • 1. Identification of immune complex antigens in sera of Indian kala-azar patients.
    Sanyal T; Ghosh DK; Sarkar D
    Indian J Exp Biol; 1991 May; 29(5):411-5. PubMed ID: 1916938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoblotting identifies an antigen recognized by anti gp63 in the immune complexes of Indian kala-azar patient sera.
    Sanyal T; Ghosh DK; Sarkar D
    Mol Cell Biochem; 1994 Jan; 130(1):11-7. PubMed ID: 8190117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complex antigens as a tool in serodiagnosis of kala-azar.
    Chakraborti T; Sarkar D; Ghosh DK
    Mol Cell Biochem; 2003 Nov; 253(1-2):191-8. PubMed ID: 14619969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complexes in Indian kala-azar.
    Sehgal S; Aikat BK; Pathania AG
    Bull World Health Organ; 1982; 60(6):945-50. PubMed ID: 6761008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar.
    Salotra P; Raina A; Negi NS
    Br J Biomed Sci; 1999; 56(4):263-7. PubMed ID: 10795370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis.
    Ghosh AK; Dasgupta S; Ghose AC
    Clin Diagn Lab Immunol; 1995 May; 2(3):291-6. PubMed ID: 7664174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.
    Ravindran R; Anam K; Bairagi BC; Saha B; Pramanik N; Guha SK; Goswami RP; Banerjee D; Ali N
    Infect Immun; 2004 Feb; 72(2):863-70. PubMed ID: 14742530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antibody responses in Indian kala-azar by immunoblot.
    Tiwari V; Jain A; Agarwal M; Mittal B; Pandey HP
    Biochem Mol Biol Int; 1995 Nov; 37(5):959-64. PubMed ID: 8624503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and glycobiological characterization of circulating immune complexes in patients with visceral leishmaniasis and post kala azar dermal leishmaniasis.
    Datta S; Modak D; Sarkar S; Saha B; Mukhopadhyay S
    Indian J Exp Biol; 2015 Jun; 53(6):321-8. PubMed ID: 26155670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological investigations on Indian kala-azar.
    Ghose AC; Haldar JP; Pal SC; Mishra BP; Mishra KK
    Clin Exp Immunol; 1980 May; 40(2):318-26. PubMed ID: 7438541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody pattern in patients with different forms of leishmaniasis (author's transl)].
    Mannweiler E; Lederer I; zum Felde I
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):397-402. PubMed ID: 352039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of components of IC purified from human sera. I. Immune complexes purified from sera of patients with SLE.
    Maire MA; Barnet M; Carpentier N; Miescher PA; Lambert PH
    Clin Exp Immunol; 1983 Feb; 51(2):215-24. PubMed ID: 6839539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The major circulating immunosuppressive activity in American visceral leishmaniasis patients is associated with a high-molecular weight fraction and is not mediated by IgG, IgG immune complexes or lipoproteins.
    Soares NM; Ferraz TP; Nascimento EG; Carvalho EM; Pontes-de-Carvalho L
    Microb Pathog; 2006 Jun; 40(6):254-60. PubMed ID: 16626930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complex mediated lesions in experimental Kala azar: an ultrastructural study.
    Jain A; Berthwal M; Tiwari V; Maitra SC
    Indian J Pathol Microbiol; 2000 Jan; 43(1):13-6. PubMed ID: 12583413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunopathology in a case of kala-azar (proceedings)].
    Pugin P; Casali P; Lambert PH; Miescher PA
    Schweiz Med Wochenschr; 1978 Oct; 108(41):1602. PubMed ID: 694498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis.
    Jamal F; Shivam P; Kumari S; Singh MK; Sardar AH; Pushpanjali ; Murugesan S; Narayan S; Gupta AK; Pandey K; Das VNR; Ali V; Bimal S; Das P; Singh SK
    PLoS One; 2017; 12(8):e0182474. PubMed ID: 28820895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.